Craft
  • Home
  •  / Avid Bioservices
Avid Bioservices

Avid Bioservices

Phase I/II Trials Products

1

FY, 2016

Revenue

$119.6 M

FY, 2022

Market Capitalization

$881.2 M

2022-11-18

Avid Bioservices Summary

Company summary

Overview
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. Avid provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Type
Public
Status
Active
Founded
1981
HQ
Tustin, CA, US | view all locations
Website
https://avidbio.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Joseph Carleone, Chairman of the Board

    • Daniel Hart

      Daniel Hart, Chief Financial Officer

      • Richard B. Hancock, Interim President and CEO

        • Mark Ziebell

          Mark Ziebell, VP General Counsel & Corporate Secretary

          Operating MetricsView all

          Phase I/II Trials Products

          1

          FY, 2016

          LocationsView all

          1 location detected

          • Tustin, CA HQ

            United States

            2642 Michelle Dr #200

          Avid Bioservices Financials

          Summary financials

          Revenue (Q1, 2023)
          $36.7M
          Gross profit (Q1, 2023)
          $9.1M
          Net income (Q1, 2023)
          $1.6M
          Cash (Q1, 2023)
          $115.1M
          EBIT (Q1, 2023)
          $2.7M
          Enterprise value
          $812.6M

          Footer menu